US 11839611
Buprenorphine dosing regimens
granted A61KA61K31/485A61K47/22
Quick answer
US patent 11839611 (Buprenorphine dosing regimens) held by Indivior UK Limited expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/485, A61K47/22, A61K47/34, A61K9/0019